Analysts Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) PT at $94.23

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been given an average recommendation of “Moderate Buy” by the fourteen analysts that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, five have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $94.23.

Several equities analysts have recently commented on the company. Stifel Nicolaus boosted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. Finally, Evercore ISI boosted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $88.90 on Friday. The stock’s 50-day simple moving average is $88.35 and its 200-day simple moving average is $83.45. GE HealthCare Technologies has a 52 week low of $62.35 and a 52 week high of $94.55. The company has a market capitalization of $40.58 billion, a price-to-earnings ratio of 25.99, a PEG ratio of 3.39 and a beta of 1.18. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same period in the previous year, the business earned $0.92 earnings per share. The business’s revenue was up .5% on a year-over-year basis. As a group, analysts expect that GE HealthCare Technologies will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Pathway Financial Advisers LLC bought a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $25,000. Fred Alger Management LLC bought a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $26,000. BNP Paribas bought a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $30,000. Riverview Trust Co bought a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $31,000. Finally, Elkhorn Partners Limited Partnership bought a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $31,000. Institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.